Case study of thrombosis and thrombocytopenia syndrome following administration of the AstraZeneca COVID-19 vaccine

Ashraf Saleh; Joel Collins

Case study of thrombosis and thrombocytopenia syndrome following administration of the AstraZeneca COVID-19 vaccine

Aust J Gen Pract. 2021 Nov 12:50.

Authors

Ashraf Saleh¹, Joel Collins²

Affiliations

¹ MBBS, MNutrSci, BMedSci, FRACGP, FARGP (Emerg Med), People First Health Group, Toowoomba, Qld.
² BSc, MBBS, FRACP, Clinical Haematologist, Qld.

PMID: 34781321

Abstract

Cerebral venous sinus thrombosis is a complication of the ChAdOx1 nCoV-19 vaccine that should elicit a high index of suspicion when patients present with persistent headache post vaccination.

MeSH terms

COVID-19 Vaccines
COVID-19*
ChAdOx1 nCoV-19
Humans
SARS-CoV-2
Thrombocytopenia* / chemically induced
Thrombosis*
Vaccines*

Substances

COVID-19 Vaccines
Vaccines
ChAdOx1 nCoV-19